Bacillus Calmette-Guerin therapy in non-muscle-invasive bladder carcinoma after renal transplantation for end-stage aristolochic acid nephropathy.

about

DNA Adducts Formed by Aristolochic Acid Are Unique Biomarkers of Exposure and Explain the Initiation Phase of Upper Urothelial Cancer.Histopathology and prognosis of de novo bladder tumors following solid organ transplantation.

P2860

Q47096788-84EE70F4-AD95-45BD-A83D-8DC9994BDB58 Q53550694-9AC9802E-6256-4528-BC74-DB303E2EFCF0

P2860

Bacillus Calmette-Guerin therapy in non-muscle-invasive bladder carcinoma after renal transplantation for end-stage aristolochic acid nephropathy.

Item

http://www.wikidata.org/entity/Q40183879

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Bacillus Calmette-Guerin thera ...... aristolochic acid nephropathy.

@en

type

Item

label

Bacillus Calmette-Guerin thera ...... aristolochic acid nephropathy.

@en

prefLabel

Bacillus Calmette-Guerin thera ...... aristolochic acid nephropathy.

@en

P1476

Bacillus Calmette-Guerin thera ...... aristolochic acid nephropathy

@en

P2093

Agnieszka Pozdzik

http://www.w3.org/2001/XMLSchema#string

Avinash Jayaswal

http://www.w3.org/2001/XMLSchema#string

Heinz H Schmeiser

http://www.w3.org/2001/XMLSchema#string

Joëlle L Nortier

http://www.w3.org/2001/XMLSchema#string

Nilufer Broeders

http://www.w3.org/2001/XMLSchema#string

Sandrine Rorive

http://www.w3.org/2001/XMLSchema#string

Thierry Quackels

http://www.w3.org/2001/XMLSchema#string

P2860

Aristolochic acid-associated urothelial cancer in Taiwan

Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs

The epidemiology, diagnosis, and management of aristolochic acid nephropathy: a narrative review.

Aristolochic acid nephropathy: a worldwide problem.

Management of Bladder Cancer following Solid Organ Transplantation.

Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid

Should intravesical Bacillus Calmette-Guérin be employed in transplant recipients with bladder carcinoma?

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update.

Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation.

Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies.

P304

199-205

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/TRI.12484

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Volker M. Arlt

Thierry Roumeguere

P577

2014-11-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25377421

http://www.w3.org/2001/XMLSchema#string

Bacillus Calmette-Guerin therapy in non-muscle-invasive bladder carcinoma after renal transplantation for end-stage aristolochic acid nephropathy.

about

P2860

P2860

Bacillus Calmette-Guerin therapy in non-muscle-invasive bladder carcinoma after renal transplantation for end-stage aristolochic acid nephropathy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698